FDA Panel Backs Shield Blood Test for Cancer Screening
FDA advisory panel recommends approval of Shield blood test for colorectal cancer screening in adults 45+. The test shows 83.1% sensitivity rate....
Mercks New Pill Cuts COVID Deaths or Hospitalizations by 50%
Merck's molnupiravir pill reduces COVID hospitalizations and deaths by 50% in clinical trials. The company plans to seek emergency FDA approval for the first oral...
FDA Approves Cervarix Cervical Cancer Vaccine
The FDA has approved Cervarix, GlaxoSmithKline's cervical cancer vaccine for girls and young women aged 10-25. The HPV vaccine shows 93% efficacy....